Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
Sequel Med Tech announced today that it integrated its twiist automated insulin delivery (AID) with the Abbott FreeStyle Libre 3 Plus sensor.
A year to the day after declaring the FDA’s clearance of its automated insulin pump, Sequel Med Tech announced that its first connected continuous glucose monitor will be Abbott’s FreeSty | Greenlit ...
The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...
MedPage Today on MSN1d
Type 2 Diabetes Patients Also Reap Benefits of Automated Insulin DeliveryOver 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...
GlobalData on MSN12h
Omnipod 5 improves glycaemic levels in people transitioning from daily injectionsIndividuals transitioning from multiple daily injections to the Omnipod 5 system experienced an average HbA1c reduction of ...
Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...
Data from the Barbara Davis Center for Diabetes at University of Colorado show pilots with type 1 diabetes are not just ...
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback